Swedencare (SECARE) Stock Overview
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
SECARE Community Fair Values
Create NarrativeSee what 15 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Top Community Narratives
The Compound Effect: From Acquisition to Integration
View narrative
Swedencare AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 21.45 |
| 52 Week High | SEK 41.95 |
| 52 Week Low | SEK 21.15 |
| Beta | 0.57 |
| 1 Month Change | 0% |
| 3 Month Change | -20.85% |
| 1 Year Change | -45.42% |
| 3 Year Change | -52.83% |
| 5 Year Change | -85.44% |
| Change since IPO | 495.83% |
Recent News & Updates
Swedencare AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
The analysts might have been a bit too bullish on Swedencare AB (publ) ( STO:SECARE ), given that the company fell...
SECARE: Future M&A Pipeline Will Drive Upside Potential
Analysts have trimmed their fair value estimate for Swedencare to SEK34 from SEK39. This reflects updated assumptions around revenue growth, profit margins, the future P/E multiple and a slightly higher discount rate.
SECARE: I Expect Slower Acquisitions To Set Up A 2027 Upswing
Analysts have trimmed their Swedencare price target from SEK 55.00 to SEK 45.00, citing updated assumptions that now reflect a slightly higher discount rate, modestly lower revenue growth expectations, a higher projected profit margin, and a reduced future P/E multiple. What’s in the News for Swedencare Swedencare is actively seeking acquisitions, with management highlighting ongoing interest in adding new features and capabilities to the group.Recent updates
Swedencare AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
The analysts might have been a bit too bullish on Swedencare AB (publ) ( STO:SECARE ), given that the company fell...SECARE: Future M&A Pipeline Will Drive Upside Potential
Analysts have trimmed their fair value estimate for Swedencare to SEK34 from SEK39. This reflects updated assumptions around revenue growth, profit margins, the future P/E multiple and a slightly higher discount rate.SECARE: I Expect Slower Acquisitions To Set Up A 2027 Upswing
Analysts have trimmed their Swedencare price target from SEK 55.00 to SEK 45.00, citing updated assumptions that now reflect a slightly higher discount rate, modestly lower revenue growth expectations, a higher projected profit margin, and a reduced future P/E multiple. What’s in the News for Swedencare Swedencare is actively seeking acquisitions, with management highlighting ongoing interest in adding new features and capabilities to the group.Swedencare's (STO:SECARE) Soft Earnings Are Actually Better Than They Appear
Shareholders appeared unconcerned with Swedencare AB (publ)'s ( STO:SECARE ) lackluster earnings report last week. We...Online And Pharma Execution Risks Will Test Pet Health Upside Potential
Catalysts About Swedencare Swedencare develops and sells pet health products across dental care, nutraceuticals, treats and veterinary pharma, with a growing focus on online and Big Box retail channels. What are the underlying business or industry changes driving this perspective?Swedencare AB (publ) Just Missed EPS By 9.9%: Here's What Analysts Think Will Happen Next
Last week saw the newest yearly earnings release from Swedencare AB (publ) ( STO:SECARE ), an important milestone in...
The Compound Effect: From Acquisition to Integration
In 2026, the story is no longer about how many companies Swedencare can buy, but how effectively it can scale its existing brands (ProDen PlaqueOff and NaturVet) into global Big Box retail and e-commerce The Pet Humanization Play Swedencare's narrative rests on three pillars: The Global Brand Portfolio: Moving from a single product company to a diversified pet health giant. The story is about cross-selling, taking a successful dental product from Sweden and putting it in 2,000 Walmart stores in the US The Channel Pivot: Swedencare is taking direct control of its destiny by moving Amazon sales inhouse and entering Big Box retail like Walmart, CVS etc.Big Box Expansion And Soft Chew Capacity Will Transform Long Term Pet Health Prospects
Catalysts About Swedencare Swedencare develops and sells pet health products and provides contract development and manufacturing services to animal health companies. What are the underlying business or industry changes driving this perspective?With A 37% Price Drop For Swedencare AB (publ) (STO:SECARE) You'll Still Get What You Pay For
The Swedencare AB (publ) ( STO:SECARE ) share price has fared very poorly over the last month, falling by a substantial...We Think Swedencare's (STO:SECARE) Solid Earnings Are Understated
Investors signalled that they were pleased with Swedencare AB (publ)'s ( STO:SECARE ) most recent earnings report...Swedencare AB (publ) Reported A Surprise Loss, And Analysts Have Updated Their Forecasts
It's been a mediocre week for Swedencare AB (publ) ( STO:SECARE ) shareholders, with the stock dropping 15% to kr39.75...
Resolving NaturVet's Challenges And Global Expansion Will Enhance Future Opportunities
Improved growth strategy for NaturVet and global market expansion aim to enhance revenue and achieve group targets.Does Swedencare (STO:SECARE) Deserve A Spot On Your Watchlist?
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Shareholder Returns
| SECARE | SE Pharmaceuticals | SE Market | |
|---|---|---|---|
| 7D | -4.5% | -0.8% | 0.4% |
| 1Y | -45.4% | -25.0% | 12.8% |
Return vs Industry: SECARE underperformed the Swedish Pharmaceuticals industry which returned -25.4% over the past year.
Return vs Market: SECARE underperformed the Swedish Market which returned 14% over the past year.
Price Volatility
| SECARE volatility | |
|---|---|
| SECARE Average Weekly Movement | 4.9% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in SE Market | 11.1% |
| 10% least volatile stocks in SE Market | 2.9% |
Stable Share Price: SECARE has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: SECARE's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 624 | Hakan Lagerberg | www.swedencare.com |
Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally. The company offers animal nutritional supplements, treats, and grooming products for dogs under the Healthy Breeds name; pet supplements and topical products for various therapeutic areas, such as orthopedics, behavior, dermatology, odontostomatology, algology, gastroenterology, urology, nephrology, and ophthalmology under the Innovet name; and support and solutions for the veterinary community under the Stratford Animal Health name. It also provides pet health supplements under the NaturVet, VETCLASSICS, and NutriScience name; pet supplements, vitamins, dental care products, ear cleaners, pilling agents, and topicals under the Pet MD name; and vet-formulated pet care products under the VetWELL name.
Swedencare AB (publ) Fundamentals Summary
| SECARE fundamental statistics | |
|---|---|
| Market cap | SEK 3.43b |
| Earnings (TTM) | SEK 80.10m |
| Revenue (TTM) | SEK 2.72b |
Is SECARE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SECARE income statement (TTM) | |
|---|---|
| Revenue | SEK 2.72b |
| Cost of Revenue | SEK 1.12b |
| Gross Profit | SEK 1.61b |
| Other Expenses | SEK 1.53b |
| Earnings | SEK 80.10m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
Oct 21, 2026
| Earnings per share (EPS) | 0.50 |
| Gross Margin | 58.99% |
| Net Profit Margin | 2.94% |
| Debt/Equity Ratio | 19.7% |
How did SECARE perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/09 10:45 |
| End of Day Share Price | 2026/09/09 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Swedencare AB (publ) is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Johan Brown | ABG Sundal Collier Sponsored |
| Adela Dashian | Jefferies LLC |
| Adrian Elmlund | Nordea Markets |